中华围产医学杂志
中華圍產醫學雜誌
중화위산의학잡지
CHINESE JOURNAL OF PERINATAL MEDICINE
2015年
5期
334-338
,共5页
张蔓丽%卢彦平%李芮冰%叶明侠%黄柯%游艳琴%汪淑娟%汪龙霞%李亚里
張蔓麗%盧彥平%李芮冰%葉明俠%黃柯%遊豔琴%汪淑娟%汪龍霞%李亞裏
장만려%로언평%리예빙%협명협%황가%유염금%왕숙연%왕룡하%리아리
骨疾病,发育性%肢畸形,先天性%外显子%高通量核苷酸序列分析%基因检测%超声检查,产前
骨疾病,髮育性%肢畸形,先天性%外顯子%高通量覈苷痠序列分析%基因檢測%超聲檢查,產前
골질병,발육성%지기형,선천성%외현자%고통량핵감산서렬분석%기인검측%초성검사,산전
Bone diseases,developmental%Limb deformities,congenital%Exons%High-throughput nucleotide sequencin%Genetic testing%Ultrasonography,prenatal
目的 探讨利用目标外显子捕获结合高通量测序技术检测胎儿骨骼畸形致病基因的效果.方法 2009年7月至2014年7月在解放军总医院进行产前检查的孕妇均于妊娠18~24周和/或30~32周行常规胎儿超声检查,其中10例孕妇超声检查提示胎儿骨骼畸形,纳入研究.超声引导下行羊膜腔穿刺术或脐静脉穿刺术留取羊水或脐带血,行染色体核型分析.取羊水或脐带血,或引产后取胎儿组织,或分娩后留取新生儿血样,同时留取胎儿/新生儿父母的静脉血,提取DNA,利用目标外显子捕获结合高通量测序技术进行248种骨骼畸形相关基因的筛查,对可疑位点进行一代测序验证.结果 10例骨骼畸形胎儿染色体核型分析均未见异常.目标外显子捕获结合高通量测序技术表明其中3例胎儿存在Ⅰ型胶原α1链(collagen,type Ⅰ,alpha-l,COL1A1)基因出现杂合突变,分别为c.3307G>A、c.1706G>C及c.2101G>A.胎儿父母双方均进行了基因组DNA一代测序,未发现突变.3例胎儿检出成纤维细胞生长因子受体3(fibroblast growth factor 3,FGFR3)基因杂合突变,其中2例为c.1138G>A,另一例为c.1118A>G.1例胎儿检出埃利伟综合征(Ellis-van Creveld syndrome,EVC)基因c.884C>G和c.982C>T复合杂合突变,一代测序证实2个突变位点分别来自于胎儿父母.另外3例胎儿未发现明确致病基因. 结论 利用目标外显子捕获结合高通量测序技术可为部分骨骼异常胎儿明确致病基因.
目的 探討利用目標外顯子捕穫結閤高通量測序技術檢測胎兒骨骼畸形緻病基因的效果.方法 2009年7月至2014年7月在解放軍總醫院進行產前檢查的孕婦均于妊娠18~24週和/或30~32週行常規胎兒超聲檢查,其中10例孕婦超聲檢查提示胎兒骨骼畸形,納入研究.超聲引導下行羊膜腔穿刺術或臍靜脈穿刺術留取羊水或臍帶血,行染色體覈型分析.取羊水或臍帶血,或引產後取胎兒組織,或分娩後留取新生兒血樣,同時留取胎兒/新生兒父母的靜脈血,提取DNA,利用目標外顯子捕穫結閤高通量測序技術進行248種骨骼畸形相關基因的篩查,對可疑位點進行一代測序驗證.結果 10例骨骼畸形胎兒染色體覈型分析均未見異常.目標外顯子捕穫結閤高通量測序技術錶明其中3例胎兒存在Ⅰ型膠原α1鏈(collagen,type Ⅰ,alpha-l,COL1A1)基因齣現雜閤突變,分彆為c.3307G>A、c.1706G>C及c.2101G>A.胎兒父母雙方均進行瞭基因組DNA一代測序,未髮現突變.3例胎兒檢齣成纖維細胞生長因子受體3(fibroblast growth factor 3,FGFR3)基因雜閤突變,其中2例為c.1138G>A,另一例為c.1118A>G.1例胎兒檢齣埃利偉綜閤徵(Ellis-van Creveld syndrome,EVC)基因c.884C>G和c.982C>T複閤雜閤突變,一代測序證實2箇突變位點分彆來自于胎兒父母.另外3例胎兒未髮現明確緻病基因. 結論 利用目標外顯子捕穫結閤高通量測序技術可為部分骨骼異常胎兒明確緻病基因.
목적 탐토이용목표외현자포획결합고통량측서기술검측태인골격기형치병기인적효과.방법 2009년7월지2014년7월재해방군총의원진행산전검사적잉부균우임신18~24주화/혹30~32주행상규태인초성검사,기중10례잉부초성검사제시태인골격기형,납입연구.초성인도하행양막강천자술혹제정맥천자술류취양수혹제대혈,행염색체핵형분석.취양수혹제대혈,혹인산후취태인조직,혹분면후류취신생인혈양,동시류취태인/신생인부모적정맥혈,제취DNA,이용목표외현자포획결합고통량측서기술진행248충골격기형상관기인적사사,대가의위점진행일대측서험증.결과 10례골격기형태인염색체핵형분석균미견이상.목표외현자포획결합고통량측서기술표명기중3례태인존재Ⅰ형효원α1련(collagen,type Ⅰ,alpha-l,COL1A1)기인출현잡합돌변,분별위c.3307G>A、c.1706G>C급c.2101G>A.태인부모쌍방균진행료기인조DNA일대측서,미발현돌변.3례태인검출성섬유세포생장인자수체3(fibroblast growth factor 3,FGFR3)기인잡합돌변,기중2례위c.1138G>A,령일례위c.1118A>G.1례태인검출애리위종합정(Ellis-van Creveld syndrome,EVC)기인c.884C>G화c.982C>T복합잡합돌변,일대측서증실2개돌변위점분별래자우태인부모.령외3례태인미발현명학치병기인. 결론 이용목표외현자포획결합고통량측서기술가위부분골격이상태인명학치병기인.
Objective To investigate the feasibility of targeted exome capture with high throughput sequencing in gene mutations related to fetal skeletal dysplasia.Methods From July 2009 to July 2014,ten fetuses with skeletal dysplasia were identified by ultrasound screening at 18-24 and/or 30-32 gestational weeks in the Chinese PLA General Hospital.Amniotic fluid or cord blood was collected for karyotyping.Amniotic fluid or cord blood,fetal tissues after labor induction,and blood samples from neonates and parents were collected and analyzed for 248 genes associated with fetal skeletal dysplasia using targeted exome capture with high throughput sequencing.Detected gene mutations were confirmed by direct Sanger sequencing reactions.Results No abnormal karyotypes were found in the ten fetuses.Three fetuses carried collagen,type Ⅰ,alpha-1 (COLIA1) gene mutations of c.3307G>A,c.1706G>C and c.2101G>A,respectively.No mutations were found in their parents,which were confirmed by direct Sanger sequencing reactions.Another three fetuses carried fibroblast growth factor 3 (FGFR3) gene mutations of c.1138G>A and c.1118A>G,respectively.One fetus carried compound heterozygous Ellis-van Creveld syndrome (EVC) gene mutations of c.884C>G and c.982C>T from her parents and were confirmed by direct Sanger sequencing reactions.No causative mutations were found in the remaining three cases.Conclusion Targeted exome capture with high throughput sequencing is a new approach for identifying causative gene mutations in fetal skeletal dysplasia.